Minyang Fu
State Key Laboratory Of Biotherapy And Cancer Center, No. 17, Block 3, Southern Renmin Road
Chengdu, 610041, China
Chengdu, 610041, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Safety pharmacology and toxicology of a novel nitroimidazooxazole antitubercular agent in SD rat and Beagle dogs.
Journal: Molecular biomedicine
Published: January 20, 2026
CD94/NKG2A-Qa-1b axis as a key modulator of vaccine responsiveness in aging populations.
Journal: Cell reports
Published: April 24, 2025
Intranasal vaccine combining adenovirus and trimeric subunit protein provides superior immunity against SARS-CoV-2 Omicron variant.
Journal: Nature biomedical engineering
Published: February 11, 2024
Correction: The Hippo signalling pathway and its implications in human health and diseases.
Journal: Signal transduction and targeted therapy
Published: January 03, 2024
A chimeric adenovirus-vectored vaccine based on Beta spike and Delta RBD confers a broad-spectrum neutralization against Omicron-included SARS-CoV-2 variants.
Journal: MedComm
Published: November 23, 2023
SARS-CoV-2 Delta and Omicron variants resist spike cleavage by human airway trypsin-like protease.
Journal: The Journal of clinical investigation
Published: July 28, 2023
The Hippo signalling pathway and its implications in human health and diseases.
Journal: Signal transduction and targeted therapy
Published: June 24, 2022
Targeting TGF-β signal transduction for fibrosis and cancer therapy.
Journal: Molecular cancer
Published: February 16, 2022
Cancer vaccines as promising immuno-therapeutics: platforms and current progress.
Journal: Journal of hematology & oncology
Published: December 23, 2021
Last Updated: 09/26/2026